Clinical Trials Browser

Phase 2 × OTHER × pazopanib × Clear all

NCT01217931 2026-01-30

Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02029001 2025-08-07

MOST plus

Phase 2 Recruiting

Neoplasm Metastasis

NCT05679921 2025-07-16

Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma

Phase 2 Recruiting

Sarcoma

NCT01767636 2025-03-03

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

38 enrolled 12 charts

Oncocytoma, renal, Carcinoma, Renal Cell

NCT06816771 2025-02-10

Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents

Phase 2 Recruiting

Recurrence, Rhabdomyosarcoma

NCT06739395 2024-12-18

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT02203760 2024-11-15

PazoDoble

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence

NCT02207309 2024-08-09

Pazopanib Maintenance Phase II

Phase 2 Terminated

1 enrolled 4 charts

Sarcoma

NCT00827372 2023-10-16

A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

Phase 2 Completed

10 enrolled 10 charts

Lymphedema

NCT02383251 2023-09-06

TAPAZ

Phase 2 Completed

Ovarian Neoplasms

NCT03798106 2023-06-12

A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma

Phase 2 Completed

Sarcoma

NCT02066285 2023-03-27

Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma

Phase 2 Completed

Chondrosarcoma, Extraskeletal Myxoid, Neoplasm Metastasis, Solitary Fibrous Tumors

NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Phase 2 Completed

29 enrolled 10 charts

Hemangiosarcoma, Sarcoma

NCT01157091 2022-06-08

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Phase 2 Completed

28 enrolled 10 charts

Carcinoma, Renal Cell

NCT02357810 2022-06-07

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

Phase 2 Completed

178 enrolled 16 charts

Liposarcoma, Sarcoma, Osteosarcoma

NCT03334409 2022-03-31

Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery

Phase 2 Terminated

5 enrolled 16 charts

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT02212015 2022-03-22

EVA

Phase 2 Terminated

26 enrolled 16 charts

Hemangiosarcoma

NCT01532687 2021-09-27

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Phase 2 Completed

54 enrolled 12 charts

Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT01392183 2021-09-20

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Phase 2 Completed

69 enrolled 15 charts

Pathologic Complete Response, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT02959554 2021-09-08

NIVOSWITCH

Phase 2 Terminated

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01743482 2021-05-14

Pazotest-01

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT02960906 2021-04-26

BIONIKK

Phase 2 Completed

Clear-cell metastatic renal cell carcinoma

NCT01361334 2021-04-08

PAZOPANIB-AML

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01610206 2021-02-25

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Phase 2 Completed

148 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01543802 2021-01-26

NOPASS

Phase 2 Terminated

Sarcoma

NCT02300545 2020-08-05

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

Phase 2 Completed

56 enrolled 11 charts

Sarcoma

NCT01692496 2020-07-23

Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

Phase 2 Completed

52 enrolled 14 charts

Liposarcoma, Neoplasm Metastasis

NCT02193152 2020-07-14

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

Phase 2 Terminated

16 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT04462445 2020-07-10

PIPELINE

Phase 2 Completed

Carcinoma, Renal Cell

NCT01466972 2020-07-08

Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib

Phase 2 Completed

30 enrolled 11 charts

Breast Neoplasms, Neoplasms

NCT01593748 2020-04-06

A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma

Phase 2 Completed

90 enrolled 12 charts

Sarcoma

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Phase 2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT01392352 2020-02-13

HYPAZ

Phase 2 Terminated

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT01442662 2020-01-31

LMS03

Phase 2 Completed

Leiomyosarcoma, Neoplasm Metastasis

NCT02393820 2019-10-29

PACSA-ORL02

Phase 2 Completed

Salivary Gland Neoplasms

NCT03379012 2019-10-22

FARETES

Phase 2 Completed

Carcinoma, Renal Cell

NCT01813136 2019-08-16

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

Phase 2 Completed

Thyroid Neoplasms

NCT01107665 2019-08-07

Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma

Phase 2 Completed

60 enrolled 16 charts

Melanoma

NCT02575066 2019-06-27

PASART-2

Phase 2 Terminated

Sarcoma

NCT01280201 2019-05-29

Pazopanib as Single Agent in Advanced NETs

Phase 2 Completed

44 enrolled 17 charts

Neuroendocrine Tumors

NCT01253369 2019-04-23

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

33 enrolled 8 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01503372 2019-02-12

PaFLO

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

NCT01731158 2019-02-06

BERAT

Phase 2 Completed

Carcinoma, Renal Cell

NCT01832259 2018-12-12

A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection

Phase 2 Completed

30 enrolled 10 charts

Adenocarcinoma of the Prostate

NCT01855724 2018-11-07

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

Phase 2 Terminated

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT01666418 2018-10-16

Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel

Phase 2 Completed

Melanoma

NCT02560012 2018-10-12

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

Phase 2 Terminated

4 enrolled 3 charts

Carcinoma, Renal Cell

NCT01158521 2018-09-12

Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer

Phase 2 Completed

25 enrolled 8 charts

Carcinoma, Renal Cell

NCT01394211 2018-07-26

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

Phase 2 Terminated

2 enrolled 3 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01361113 2018-04-25

Neoadjuvant Pazopanib in Renal Cell Carcinoma

Phase 2 Completed

21 enrolled 10 charts

Carcinoma, Renal Cell